GREEN GENES
Live / Applied — Suspended — suspension check completed, case still suspended (as of 11 Sept 2025)
What this means for you
Not registered yet, but its 20 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98558948
- Mark type
- Design + words
- Filed
- 20 May 2024
- Attorney of record
- Jeffrey H. Greene
Goods and services
- Class 001 — Chemicals: Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; Synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins
- Class 042 — Scientific and technological services: Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services
Owner
- Camena Bioscience Limited, SAFFRON WALDEN, Essex, GB
Prosecution history
- 11 Sept 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 10 Mar 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 10 Mar 2025 — LETTER OF SUSPENSION E-MAILED
- 10 Mar 2025 — SUSPENSION LETTER WRITTEN
- 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Dec 2024 — NON-FINAL ACTION E-MAILED
- 18 Dec 2024 — NON-FINAL ACTION WRITTEN
- 04 Dec 2024 — ASSIGNED TO EXAMINER
- 25 Nov 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 25 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 May 2024 — NEW APPLICATION ENTERED